The announcement follows two years of accelerated testing and regulatory navigation. Neuralink launched its first human trial in 2024, two years after the US Food and ...
Uncovering the source of the discrepancy can involve scrutinizing estimating practices, material pricing, cost allocation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback